BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 32248666)

  • 21. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
    Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
    Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    Zeriouh W; Nani A; Belarbi M; Dumont A; de Rosny C; Aboura I; Ghanemi FZ; Murtaza B; Patoli D; Thomas C; Apetoh L; Rébé C; Delmas D; Khan NA; Ghiringhelli F; Rialland M; Hichami A
    PLoS One; 2017; 12(2):e0170823. PubMed ID: 28212423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. γ-Aminobutyric acid inhibits the proliferation and increases oxaliplatin sensitivity in human colon cancer cells.
    Song L; Du A; Xiong Y; Jiang J; Zhang Y; Tian Z; Yan H
    Tumour Biol; 2016 Nov; 37(11):14885-14894. PubMed ID: 27644246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation.
    Zaafar DK; Zaitone SA; Moustafa YM
    PLoS One; 2014; 9(6):e100562. PubMed ID: 24971882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
    Wu S; Wang X; Chen J; Chen Y
    Biochem Biophys Res Commun; 2013 May; 434(4):898-903. PubMed ID: 23624503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
    Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
    Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.
    Moser C; Lang SA; Kainz S; Gaumann A; Fichtner-Feigl S; Koehl GE; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Nov; 6(11):2868-78. PubMed ID: 18025273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.
    Scotland S; Saland E; Skuli N; de Toni F; Boutzen H; Micklow E; Sénégas I; Peyraud R; Peyriga L; Théodoro F; Dumon E; Martineau Y; Danet-Desnoyers G; Bono F; Rocher C; Levade T; Manenti S; Junot C; Portais JC; Alet N; Récher C; Selak MA; Carroll M; Sarry JE
    Leukemia; 2013 Nov; 27(11):2129-38. PubMed ID: 23568147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells.
    Park J; Lee GE; An HJ; Lee CJ; Cho ES; Kang HC; Lee JY; Lee HS; Choi JS; Kim DJ; Choi JS; Cho YY
    Arch Pharm Res; 2021 Dec; 44(12):1091-1108. PubMed ID: 34750753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo.
    Jeng LB; Kumar Velmurugan B; Chen MC; Hsu HH; Ho TJ; Day CH; Lin YM; Padma VV; Tu CC; Huang CY
    J Cell Physiol; 2018 Sep; 233(9):7134-7142. PubMed ID: 29574877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM; Moon JY; Ryu JY; Cho SK
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice.
    Zhu B; Shang B; Li Y; Zhen Y
    Mol Med Rep; 2016 May; 13(5):4159-66. PubMed ID: 27035417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin and metformin additively attenuate IL1β-induced malignant potential of colon cancer.
    Moon HS; Mantzoros CS
    Endocr Relat Cancer; 2013 Dec; 20(6):849-59. PubMed ID: 24157941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
    Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
    Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
    J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes.
    Shan B; Zhao R; Zhou J; Zhang M; Qi X; Wang T; Gong J; Wu Y; Zhu Y; Yang W; Zhang Y; Wang G; Li X
    Biomed Res Int; 2020; 2020():8916729. PubMed ID: 32851091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.